Expanded Access Programme: looking for a common definition

Therapeutic use of an unauthorised drug (or of an authorised drug for an unauthorised indication) for patients with a life-threating disease is permitted outside a clinical trial as an Expanded Access Programme (EAP). The regulations regarding EAPs is not the same all over the world. For example, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Iudicello, Antonella, Alberghini, Lucia, Benini, Giulia, Mosconi, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711042/
https://www.ncbi.nlm.nih.gov/pubmed/26758369
http://dx.doi.org/10.1186/s13063-015-1108-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711042/
https://www.ncbi.nlm.nih.gov/pubmed/26758369
http://dx.doi.org/10.1186/s13063-015-1108-0

Ejemplares similares